Press

Myeloma UK and the UK Myeloma Research Alliance launch new research programme

Musical stars unite to raise funds for Myeloma UK

Music stars Nicole and Natalie Appleton showed their support for national blood cancer charity Myeloma UK this week by attending a benefit performance of Six the Musical.

Myeloma Grand Rounds: a training mechanism to speed up diagnosis in secondary care

To help raise awareness of myeloma in secondary care Myeloma UK, the only charity in the UK dealing exclusively with myeloma, is encouraging hospitals to hold a Myeloma Grand Round.

New blood cancer drug combinations to be tested in latest clinical trial

The latest trial in the Myeloma UK Clinical Trial Network, MUK Twelve, has launched. The trial will test selinexor in combination for the first time. Selinexor is the first in a new family of drugs known as Selective Inhibitor of Nuclear Export (SINE™) compounds. It works by blocking the action of a protein (XPO1) in the nucleus of myeloma cells.

PRESS RELEASE: Myeloma UK Garden at RHS Chelsea Flower Show 2018

The Myeloma UK Garden by Gold medal winning designers breathes life into RHS Chelsea Flower Show 2018

Ixazomib approved for use on the NHS in England and Wales

Myeloma patients in England and Wales will now be able to access the new myeloma treatment, ixazomib (Ninlaro ®) on the NHS, after the National Institute for Health and Care Excellence (NICE) approved it for use, through the Cancer Drugs Fund (CDF).

MEDIA STATEMENT: Innovative immunotherapy drug approved for use in Scotland

PRESS RELEASE: Myeloma UK launches first UK-wide stratified medicine trial